The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
Jean-Guy Boiteau
Advertisement
Jean-Guy Boiteau is head of process research and development at Nestle Skin Health.
Articles by Jean-Guy Boiteau
Advertisement
Latest Updated Articles
Determination of Dermal PDE for Pharmaceutical ProductsPublished: January 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
